News tagged with lipitor
MRIs could become powerful tools for monitoring cholesteral therapy
MRI scanning could become a powerful new tool for assessing how well cholesterol drugs are working, according to Loyola University Health System cardiologist Binh An P. Phan, MD.
Medical research
Oct 14, 2011 |
3.7 / 5 (3) |
2
Pfizer maneuvers to protect Lipitor from generics
(AP) -- Lipitor is so valuable that its maker, Pfizer Inc., is practically paying people to keep taking the blockbuster cholesterol medicine after generic competition hits the U.S. market this week.
Medications
Nov 29, 2011 |
3.5 / 5 (2) |
0
The future of drugs is all in the family
In a first-ever comprehensive study of the species origins of nature-derived drugs, it is shown that drug-producing species are concentrated and clustered in a limited number of families, refuting the conventional view that ...
Medications
Sep 06, 2011 |
5 / 5 (1) |
0
US approves India's Ranbaxy to make generic Lipitor
Indian pharmaceutical giant Ranbaxy won US regulatory approval to make the first generic version of cholesterol lowering drug Lipitor, a Pfizer product whose patent expired Wednesday.
Medications
Dec 01, 2011 |
5 / 5 (1) |
0
Counterfeit drugs becoming big business worldwide
(AP) -- The discovery that a fake version of the widely used cancer medicine Avastin is circulating in the United States is raising new fears that the multibillion-dollar drug-counterfeiting trade is increasingly ...
Medications
Feb 16, 2012 |
5 / 5 (1) |
1
U-M researchers find new way to clear cholesterol from the blood
Researchers at the University of Michigan have identified a new potential therapeutic target for lowering cholesterol that could be an alternative or complementary therapy to statins.
Cardiology
Apr 10, 2013 |
5 / 5 (1) |
0
|
Cholesterol drugs might boost kidney cancer survival
(HealthDay)—Cholesterol-lowering statin drugs that are taken by millions of Americans might also improve survival from a type of kidney cancer called renal cell carcinoma, a new study suggests.
Cancer
May 07, 2013 |
5 / 5 (1) |
0
Atorvastatin
Atorvastatin (INN) ( /əˌtɔrvəˈstætən/), sold by Pfizer under the trade name Lipitor, is a member of the drug class known as statins, used for lowering blood cholesterol. It also stabilizes plaque and prevents strokes through anti-inflammatory and other mechanisms. Like all statins, atorvastatin works by inhibiting HMG-CoA reductase, an enzyme found in liver tissue that plays a key role in production of cholesterol in the body.
Atorvastatin was first synthesized in 1985 by Bruce Roth while working at Parke-Davis Warner-Lambert Company (now Pfizer). With 2008 sales of US$12.4 billion, Lipitor was the top-selling branded pharmaceutical in the world. U.S. patent protection was scheduled to expire in June 2011. However, Pfizer made an agreement with Ranbaxy Laboratories to delay the generic launch in the U.S. until November 30, 2011.
For more information about Atorvastatin, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
